Human papillomavirus assay in genital warts--correlation with symptoms

Int J STD AIDS. 2007 May;18(5):329-34. doi: 10.1258/095646207780749574.

Abstract

Our purpose was to investigate the human papillomavirus (HPV) type distribution using the Hybrid Capture 2 (HC2) Microplate assay in males. We tested a urethral swab from 550 HIV-negative males with genital warts and 64 HIV-negative males clinically free of genital warts, partners of HPV-infected females, using the HC2 Microplate assay. A perianal swab was also obtained from patients with perianal warts. In the first group, HPV DNA of any type was detected in 280 (50.9%) patients. Relatively few patients with urethral or perianal warts demonstrated a negative test (both P < 0.0001). Low-risk types were commoner, accounting for 60.0% of the HPV cases, high/intermediate-risk types accounted for 23.6%, while 46 men (16.4%) were infected with both types. Of 13 subjects (20.3%) of the second group who tested positive for HPV DNA, 61.5% were infected by low-risk types, 23.1% by high/intermediate-risk types and 15.4% had a dual infection. In conclusion, male partners of infected females and males with genital warts are predominantly infected by low-risk HPV types, but a substantial proportion is also or only affected by high-risk types.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Alphapapillomavirus / classification
  • Alphapapillomavirus / isolation & purification*
  • Alphapapillomavirus / pathogenicity
  • Anal Canal / virology
  • Condylomata Acuminata / complications
  • Condylomata Acuminata / virology*
  • Humans
  • Male
  • Middle Aged
  • Perineum / virology
  • Polymerase Chain Reaction
  • RNA Probes*
  • Risk Factors
  • Sensitivity and Specificity
  • Sexual Partners
  • Urethra / virology

Substances

  • RNA Probes